When ophthalmologist Emily Cole, MD, steps into the neonatal intensive care unit (NICU) at Children's Hospital Colorado to evaluate an infant's eyes for a disease called retinopathy of prematurity ...

Interview of a lead researcher performing hypnosis-based simulated surgery for weight loss with promising early results.

Narwal Prime Day is Here! From July 8th to 11th, Grab Freo Z10 at Its Lowest Price Ever. Save $450 (CA$650) – Final Price ...

After 42 years of toughness, Casio G-Shock founder Kikuo Ibe delves into how the series continues to withstand the passage of ...

The story so far: The Bombay High Court, on November 12, pulled up the Maharashtra and Union governments for an “extremely casual” approach to the disturbing number of deaths due to malnutrition among ...

First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel nasal spray designed to rapidly ...

The holidays are a special time of year for everyone. You can almost feel it in the air, especially in the New Orleans area,” ...

Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Revuforj ® (revumenib) was named Best New Drug at the ...

A New Brunswick mom's 10-year-old ended up in emergency after drinking two energy drinks, sparking calls for a ban on sales ...

EXXUA is a novel oral selective serotonin 5HT1a receptor agonist indicated for the treatment of major depressive disorder (MDD) in adults. EXXUA is also being developed for other psychiatric disorders ...

DENVER, CO / ACCESS Newswire / December 18, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central ...

Cardiac Ablation Market OverviewThe cardiac ablation market is set to grow at an impressive CAGR of approximately 13% over the forecast period, driven by a combination of clinical, technological, and ...